05.01.08
Critical Therapeutics Signs Definitive Agreement to Merge With Cornerstone BioPharma^®

03.02.08
Cornerstone BioPharma^®, Inc. Introduces New AlleRx Dose Pack^®

07.09.07
Cornerstone BioPharma, Inc. and SJ Pharmaceuticals, LLC Sign Co-Promotion Agreement

01.12.07
Cornerstone BioPharma, J-Med Pharmaceuticals and Sovereign Pharmaceuticals Settle Pending Litigation Concerning U.S. Patent No. 6,270,796 and AlleRx™ Dose Pack

10.26.06
Cornerstone BioPharma, Inc. Obtains Exclusive Licensing Rights for Spectracef^®

07.24.06
Cornerstone BioPharma, Inc. Announces Sales Force Additions in Five Top Markets

06.05.06
Cornerstone BioPharma, Inc. and Athlon Pharmaceuticals Sign Co-Promotion Agreement

03.07.06
Cornerstone BioPharma Announces Discontinuation of Co-Promotion Agreement with Lupin Pharmaceuticals Inc.

03.01.06
Cornerstone BioPharma, Inc. and ASCEND Therapeutics Sign Co-Promotion Agreement

09.28.05
Cornerstone BioPharma, Inc. Appoints Alastair McEwan as CFO

06.14.05
Cornerstone BioPharma Announces FDA Approval of BALACET 325

05.12.05
Triangle Business Journal Recognizes Cornerstone President Craig Collard With 40 Under 40 Entrepreneurial Award

05.12.05
Cornerstone BioPharma Names Dr. Brian Dickson Chief Medical Officer